Search This Blog

Wednesday, April 29, 2026

Chiesi to acquire KalVista Pharmaceuticals for $27.00 per share in cash

 

Chiesi to acquire KalVista Pharmaceuticals for $27.00 per share in cash in tender offer

  • Transaction values KalVista at about $1.9 billion, according to the definitive agreement with Chiesi Group.
  • Closing of the acquisition is expected in Q3 2026.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)